ATE67932T1 - Pharmazeutische zusammensetzungen fuer suppositorien. - Google Patents

Pharmazeutische zusammensetzungen fuer suppositorien.

Info

Publication number
ATE67932T1
ATE67932T1 AT87108631T AT87108631T ATE67932T1 AT E67932 T1 ATE67932 T1 AT E67932T1 AT 87108631 T AT87108631 T AT 87108631T AT 87108631 T AT87108631 T AT 87108631T AT E67932 T1 ATE67932 T1 AT E67932T1
Authority
AT
Austria
Prior art keywords
suppositories
pharmaceutical compositions
suppository
pharmaceutically acceptable
molecular weight
Prior art date
Application number
AT87108631T
Other languages
German (de)
English (en)
Inventor
Yamashita Chikamasa
Ishida Kouzo
Gohachiro Miyamoto
Ishikawa Muneyoshi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of ATE67932T1 publication Critical patent/ATE67932T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/15—Suppositories

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT87108631T 1986-06-16 1987-06-16 Pharmazeutische zusammensetzungen fuer suppositorien. ATE67932T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP61141086A JPS62298530A (ja) 1986-06-16 1986-06-16 坐薬用医薬組成物
EP87108631A EP0253143B1 (en) 1986-06-16 1987-06-16 Pharmaceutical compositions for suppository

Publications (1)

Publication Number Publication Date
ATE67932T1 true ATE67932T1 (de) 1991-10-15

Family

ID=15283879

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87108631T ATE67932T1 (de) 1986-06-16 1987-06-16 Pharmazeutische zusammensetzungen fuer suppositorien.

Country Status (10)

Country Link
US (1) US4784855A (enExample)
EP (1) EP0253143B1 (enExample)
JP (1) JPS62298530A (enExample)
AT (1) ATE67932T1 (enExample)
CA (1) CA1283605C (enExample)
DE (1) DE3773440D1 (enExample)
DK (1) DK167559B1 (enExample)
ES (1) ES2039377T3 (enExample)
IE (1) IE59668B1 (enExample)
PT (1) PT85086B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989009066A1 (en) * 1988-03-24 1989-10-05 Bukh Meditec A/S Controlled release composition
US5242391A (en) * 1990-04-25 1993-09-07 Alza Corporation Urethral insert for treatment of erectile dysfunction
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
JP2007016052A (ja) * 1998-03-03 2007-01-25 Eisai R & D Management Co Ltd 抗痴呆薬を含有した経皮適用製剤又は坐剤
WO2004054554A1 (en) * 2002-12-13 2004-07-01 Euro-Celtique S.A. Transdermal buprenorphine to treat pain in sickle cell crisis
US7135436B2 (en) * 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
US9415034B2 (en) * 2005-01-05 2016-08-16 National Defense Medical Center Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B)
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
WO2008153611A2 (en) 2007-05-25 2008-12-18 Qlt Usa, Inc. Sustained delivery formulations of risperidone compounds
GB2481017B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
WO2018165183A1 (en) * 2017-03-06 2018-09-13 Tactus Therapeutics, Inc. Abuse deterrent opioid formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2870061A (en) * 1956-11-08 1959-01-20 Mead Johnson & Co Concentrates of dialkyl sulfosuccinates
US3474101A (en) * 1960-09-05 1969-10-21 Reckitt & Sons Ltd Thebaine and oripavine derivatives
DE2229770A1 (de) * 1972-06-19 1974-01-10 Boehringer Sohn Ingelheim N-(heteroarylmethyl)-7alpha-acyl6,14-endoaethenotetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung
US4004010A (en) * 1972-06-19 1977-01-18 Boehringer Ingelheim Gmbh Pharmaceutical compositions containing an N-(furyl-methyl)-7α-acyl-6,14-(endoetheno or endoethano)-tetrahydro-nororipavine or -northebaine and method of use
DE2230154A1 (de) * 1972-06-21 1974-01-17 Boehringer Sohn Ingelheim N-(heteroaryl-methyl)-6,14-endoaetheno7alpha-hydroxyalkyl-tetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung
JPS54157820A (en) * 1978-05-30 1979-12-13 Res Inst For Prod Dev Preparation of multi-layered suppository base
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
GB8332556D0 (en) * 1983-12-06 1984-01-11 Reckitt & Colmann Prod Ltd Analgesic compositions
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4699776A (en) * 1985-06-28 1987-10-13 R. P. Scherer Corporation Suppositories containing analgesics, antipyretics or anti-inflammatory agents

Also Published As

Publication number Publication date
CA1283605C (en) 1991-04-30
JPS62298530A (ja) 1987-12-25
DE3773440D1 (de) 1991-11-07
IE871522L (en) 1987-12-16
JPH0475889B2 (enExample) 1992-12-02
IE59668B1 (en) 1994-03-09
EP0253143B1 (en) 1991-10-02
DK167559B1 (da) 1993-11-22
EP0253143A3 (en) 1989-08-23
DK305087A (da) 1987-12-17
US4784855A (en) 1988-11-15
ES2039377T3 (es) 1993-10-01
DK305087D0 (da) 1987-06-16
PT85086A (en) 1987-07-01
PT85086B (pt) 1990-03-08
EP0253143A2 (en) 1988-01-20

Similar Documents

Publication Publication Date Title
DE3789196D1 (de) Fibrinolytische zusammensetzung.
ES541521A0 (es) Un procedimiento para la preparacion de piridazinaminas.
DE3773440D1 (de) Pharmazeutische zusammensetzungen fuer suppositorien.
AU579012B2 (en) Compositions for the preparation of microparticles permitting a prolonged release of a biologically active substance
EG17753A (en) Novel pharmacological compounds
FI933740A0 (fi) Peg-interferonkonjugat
FI855117A0 (fi) Segmenttipolyestereitä ja niiden kaltaisia yhdisteitä käytettäviksi lianirrotusaineina pesuainekoostumuksissa
GR3004114T3 (enExample)
SE8404065D0 (sv) Novel biologically active compounds
ES2062375T3 (es) Composiciones farmaceuticas que contienen un complejo de zinc.
EP0153152A3 (en) (2-oxo-1,2,3,5-tetrahydroimidazo-/2,1-b/quinnazolinyl)-oxyalkylamides, their preparation, compositions containing them and their use in making medicaments
SE8600658D0 (sv) Novel composition of matter
SE8302979L (sv) Piperazinderivat, deras framstellning och farmaceutiska kompositioner innehallande dessa
SE8306225L (sv) 2-piperazinyl-kinazolinderivat, deras framstellning och farmaceutiska kompositioner innehallande desamma
ITMI912044A1 (it) Composizione farmaceutica solida per uso orale a base di dapiprazolo
IT1204778B (it) Formulazioni farmaceutiche iniettabili di principi attivi ad attivita' anestetica generale
EP0127389A3 (en) N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor
IE873162L (en) Pesticidal compositions
GR3007498T3 (enExample)
MY100752A (en) Pharmaceutical composition for combating malaria.
DE3578172D1 (de) 2,5-pyrrolidindion-derivate mit antiarrhythmischer wirkung.
FI905922A0 (fi) Antagonister foer a-adrenerga receptorer.
IT8622051A0 (it) Composizioni farmaceutiche adattivita' cicatrizzante.
IT8720229A0 (it) Composizioni farmaceutiche adattivita' spasmolitica contenente come principio attio idanpramina

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties